RBPJL

RBPJL (RBP-L) is a sequence-specific DNA-binding transcription factor that serves as the tissue-restricted subunit of the trimeric PTF1 complex, driving terminal differentiation programs in pancreatic acinar cells and contributing to osteoblast development (PMID:9111338, PMID:16354684, PMID:20398665). It recognizes a DNA sequence almost identical to that bound by RBP-J but, unlike RBP-J, does not interact with Notch proteins (PMID:9111338). Within PTF1, RBPJL is recruited by P48/PTF1a through two conserved tryptophan-containing motifs that mimic the Notch intracellular domain docking motif; because RBPJL occupies this site yet cannot bind NotchIC, the resulting PTF1-L complex is rendered Notch-independent (PMID:16354684). Replacement of RBP-J by RBPJL in PTF1 drives final maturation of acinar cells by maximizing secretory digestive enzyme gene expression (e.g., CTRB1/Ctrb), stimulating mitochondrial metabolism, and completing the secretory apparatus (PMID:20398665, PMID:29302047). RBPJL also directly binds and represses the Arid5a promoter, thereby suppressing IL-6/STAT3 inflammatory signaling and limiting acinar cell damage in pancreatitis models (PMID:35725649). Beyond the pancreas, RBPJL is translocated to the nucleus by Fam102a to activate Osterix (Sp7), supporting osteoblastic bone formation (PMID:39747056). The P48–RBP interaction is required for proper development, with disrupting mutations associated with human pancreatic and cerebellar agenesis (PMID:16354684).

1. 1997 High

   Established that RBP-L is a sequence-specific DNA-binding factor closely related to RBP-J in target recognition but mechanistically distinct in being unable to engage Notch, defining it as a Notch-independent counterpart.

   Evidence DNA binding assays and multiple in vivo/in vitro protein-protein interaction assays against mouse Notch proteins

   PMID:9111338

   Open questions at the time

   • Did not identify physiological target genes or in vivo binding sites
   • Cellular and tissue context of activity not yet defined
2. 1997 Medium

   Showed RBP-L can functionally cooperate with EBNA-2 in transcriptional activation without detectable direct physical interaction, distinguishing its coactivator behavior from RBP-J.

   Evidence Transcriptional activation assays plus multiple interaction assays

   PMID:9111338

   Open questions at the time

   • Mechanism of cooperation without binding unresolved
   • Relevance to endogenous RBP-L function unclear
3. 1999 Medium

   Mapped cell-type-specific RBP-L expression and revealed dual promoter usage, indicating tissue-restricted and activity-regulated transcriptional control of the gene.

   Evidence Knock-in nlacZ reporter and beta-galactosidase histochemistry in mice

   PMID:10502683

   Open questions at the time

   • No functional consequence of expression pattern tested
   • Neuronal role of RBP-L not characterized
4. 2006 High

   Defined RBPJL as the third subunit of the PTF1 complex recruited by P48/PTF1a via tryptophan motifs that mimic NotchIC docking, explaining how PTF1-L is rendered Notch-independent and targets acinar-specific promoters.

   Evidence Reciprocal co-IP, tryptophan-motif mutagenesis, ChIP, and in vitro binding

   PMID:16354684

   Open questions at the time

   • Full set of acinar target genes not enumerated here
   • Structural basis of motif mimicry not resolved
5. 2006 High

   Linked loss of the P48–RBP interaction to a human developmental disorder, establishing that this assembly is required for normal embryonic development.

   Evidence Mutagenesis of RBP-interacting motifs plus human disease variant analysis (pancreatic and cerebellar agenesis)

   PMID:16354684

   Open questions at the time

   • Did not separate RBPJL-specific from RBP-J-specific contributions to the disorder
6. 2010 High

   Demonstrated that swapping RBP-J for RBPJL in PTF1 drives the final maturation of acinar cells, directly tying RBPJL to secretory enzyme gene output, mitochondrial metabolism, and the secretory apparatus.

   Evidence Rbpjl knockout mice with genome-wide mRNA profiling and ChIP for direct targets

   PMID:20398665

   Open questions at the time

   • Mechanism of partial PTF1-J substitution not fully defined
   • Direct vs indirect regulation of metabolic genes not separated
7. 2018 Medium

   Connected a destabilizing RBPJL variant (p.Thr280Met) to reduced transactivation of acinar promoters, providing human-relevant functional evidence for RBPJL's role in exocrine enzyme gene expression.

   Evidence Luciferase reporter assays, allelic protein stability analysis, and Rbpjl knockdown in mouse acinar cells

   PMID:29302047

   Open questions at the time

   • Disease penetrance and in vivo consequence of the variant not established
   • Single-lab functional assays
8. 2022 Medium

   Identified Arid5a as a direct RBPJL repression target, revealing a mechanism by which RBPJL restrains IL-6/STAT3 inflammatory signaling and protects acinar cells.

   Evidence ChIP, EMSA, dual-luciferase reporter, overexpression/knockdown, and cerulein pancreatitis mouse model

   PMID:35725649

   Open questions at the time

   • Single lab
   • Whether repression occurs within the PTF1 complex context not defined
9. 2025 Medium

   Extended RBPJL function beyond the pancreas by showing Fam102a-mediated nuclear translocation activates Osterix to promote osteoblast bone formation.

   Evidence Co-IP, nuclear translocation assays, and Fam102a-deletion / Rbpjl-mutant knockout mouse models with bone phenotyping

   PMID:39747056

   Open questions at the time

   • Whether PTF1-like assembly operates in osteoblasts unknown
   • Single lab; direct binding to Osterix promoter not established here

• How RBPJL switches between transcriptional activation (digestive enzymes, Osterix) and direct repression (Arid5a), and what determines its tissue-specific partner usage, remains unresolved.
• No structural model of RBPJL bound to distinct cofactors
• Mechanism toggling activation vs repression unknown
• Neuronal RBP-L function uncharacterized in the corpus